» Articles » PMID: 36443964

Clinical Trials of Non-Coding RNAs As Diagnostic and Therapeutic Biomarkers for Central Nervous System Injuries

Overview
Date 2022 Nov 29
PMID 36443964
Authors
Affiliations
Soon will be listed here.
References
1.
Bache S, Rasmussen R, Rossing M, Laigaard F, Nielsen F, Moller K . MicroRNA Changes in Cerebrospinal Fluid After Subarachnoid Hemorrhage. Stroke. 2017; 48(9):2391-2398. PMC: 5571886. DOI: 10.1161/STROKEAHA.117.017804. View

2.
Taubel J, Hauke W, Rump S, Viereck J, Batkai S, Poetzsch J . Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study. Eur Heart J. 2020; 42(2):178-188. PMC: 7954267. DOI: 10.1093/eurheartj/ehaa898. View

3.
Sanuki R, Onishi A, Koike C, Muramatsu R, Watanabe S, Muranishi Y . miR-124a is required for hippocampal axogenesis and retinal cone survival through Lhx2 suppression. Nat Neurosci. 2011; 14(9):1125-34. DOI: 10.1038/nn.2897. View

4.
Wang Y, Ma Z, Kan P, Zhang B . The Diagnostic Value of Serum miRNA-221-3p, miRNA-382-5p, and miRNA-4271 in Ischemic Stroke. J Stroke Cerebrovasc Dis. 2017; 26(5):1055-1060. DOI: 10.1016/j.jstrokecerebrovasdis.2016.12.019. View

5.
Fedorchak G, Rangnekar A, Onks C, Loeffert A, Loeffert J, Olympia R . Saliva RNA biomarkers predict concussion duration and detect symptom recovery: a comparison with balance and cognitive testing. J Neurol. 2021; 268(11):4349-4361. PMC: 8505318. DOI: 10.1007/s00415-021-10566-x. View